OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6113-6121

  Yun, Theodore J ^a   Chaudhary, Preet M ^a   Shu, Geraldine L ^a   Kimble Frazer, J ^b,c   Ewings, Maria K ^a   Schwartz, Stephen M ^a   Pascual, Virginia ^b   Hood, Leroy E ^a   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CALCULATION; CELL ISOLATION; DENDRITIC CELL; DNA LIBRARY; FLOW CYTOMETRY; GENE EXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MOLECULAR CLONING; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD40; CELL LINE; CELL MEMBRANE; CRICETINAE; DENDRITIC CELLS; GLYCOPROTEINS; HUMANS; KIDNEY; LYMPHOID TISSUE; ORGAN SPECIFICITY; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; UP-REGULATION;

EID: 0032400933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Parker, D. C. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331.
2. MacLennan, I. C. M. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.
3. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
4. Kelsoe, G. 1996. Life and death in germinal centers (redux). Immunity 4:107.
5. Ahmed, R., and D. Gray. 1996. Immunologic memory and protective immunity: understanding their relation. Science 272:54.
6. Lindhout, E., G. Koopman, S. T. Pals, and C. de Groot. 1997. Triple check for antigen specificity of B cells during germinal center reactions. Immunol. Today 18:573.
7. MacLennan, I. C. M., A. Gulbranson-Judge, K. M. Toellner, M. Casamayor-Palleja, E. Chan, D. M. Sze, S. A. Luther, and H. A. Orbea. 1997. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156:53.
8. Liu, Y.-J., and C. Arpin. 1997. Germinal center development. Immunol. Rev. 156:111.
9. Gu, H., D. Tarlinton, W. Muller, K. Rajewsky, and I. Forster. 1991. Most peripheral B cells in mice are ligand selected. J. Exp. Med. 173:1357.
10. Gruss, H.-J., and S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85:3378.
11. Ramesh, N., T. Morio, R. Fuleihan, M. Worm, A. Horner, E. Tsitsikov, E. Castigli, and R. S. Geha. 1995. CD40-CD40 ligand (CD40L) interactions and X-linked hyper-IgM syndrome (HIGMX-1). Clin. Immunol. Immunopathol. 76: S208.
12. Matsumoto, M., Y. X. Fu, H. Molina, and D. D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137.
13. Liu, Y.-J., and J. Banchereau. 1996. Mutant mice without B lymphocyte follicles. J. Exp. Med. 184:1207.
14. Kosco-Vilbois, M. H., J. Y. Bonnefoy, and Y. Chvatchko. 1997. The physiology of murine germinal center reactions. Immunol. Rev. 156:127.
15. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175.
16. Garrone, P., E. M. Neidhardt, E. Garcia, L. Galibert, C. van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 82:1265.
17. Schattner, E. J., K. B. Elkon, D. H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
18. Worm, M., and R. S. Geha. 1995. CD40-mediated lymphotoxin-α expression on human B cells is tyrosine kinase dependent. Eur. J. Immunol. 25:2438.
19. Tew, J. G., J. Wu, D. Qin, S. Helm, G. F. Burton, and A. K. Szakal 1997. Follicular dendritic cells and presentation of antigen and costimulatory signal to B cells. Immunol. Rev. 156:39.
20. Liu, Y.-J., G. Grouard, O. de Bouteiller, and J. Banchereau. 1996. Follicular dendritic cells and germinal centers. Int. Rev. Cytology 166:139.
21. Tsunoda, R., N. Nakayama, K. Onozaki, E. Heinan, N. Cormann, C. Kinet-Denoël, and M. Kojima. 1990. Isolation and long-term cultivation of human tonsil follicular dendritic cells. Virchows Arch. B Cell Pathol. 59:95.
22. Clark, E. A., K. Grabstein, and G. L. Shu. 1992. Cultured human follicular dendritic-like cells: growth, characteristics and interactions with B lymphocytes. J. Immunol. 148:3327.
23. Clark, E. A., K. H. Grabstein, A. M. Gown, M. Skelly, T. Kaisho, T. Hirano, and G. L. Shu. 1995. Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1. J. Immunol. 155:545.
24. Kim, H.-S., X. Zhang, and Y. S. Choi. 1994. Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes. J. Immunol. 153: 2951.
25. Lindhout, E., A. Lakeman, M. L. C. M. Mevissen, and C. de Groot 1994. Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines. J. Exp. Med. 179:1173.
26. Orscheschek, K., H. Merz, B. Schlegelbereger, and A. C. Feller. 1994. An immortalized cell line with features of human follicular dendritic cells: antigen and cytokine expression analysis. Eur. J. Immunol. 24:2682.
27. Grouard, G., O. de Bouteiller, J. Banchereau, and Y.-J. Liu. 1995. Human follicular dendritic cells enhance cytokine dependent growth and differentiation of CD40-activated B cells. J. Immunol. 155:3345.
28. Schriever, F., A. S. Freedman, G. Freeman, E. Messner, G. Lee, J. Daley, and L. M. Nadler. 1989. Isolated follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169:2043.
29. Lebecque, S., O. de Bouteiller, C. Arpin, J. Banchereau, and Y.-J. Liu. 1997. Germinal center founder cells display propensity for apoptosis before the onset of somatic mutation. J. Exp. Med. 185:563.
30. Lindhout, E., A. Lakeman, and C. de Groot. 1995. Follicular dendritic cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisitng endonuclease. J. Exp. Med. 181:1985.
31. Simonet, W. S., D. L. Lacey, C.R. Dunstan, M. Kelley, M.-S. Chang, R. Lüthy, H. Q. Nguyen, S. Wooden, L. Bennet, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309.
32. Yasuda, H., N. Shima, N. Nakagawa, S. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama, et al. 1998. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329.
33. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, W. J. Boyle, and W. S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260.
34. Yamaguchi, K., M. Kinosaki, M. Goto, F. Kobayashi, E. Tsuda, T. Morinaga, and K. Higashio. 1998. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J. Biol. Chem. 273:5117.
35. Lacey, D. L., E. Timms, H.-L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliot, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165.
36. Wong, B. R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F. S. Bartlett, W. N. Frankel, S. Y. Lee, and Y. Choi. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190.
37. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H.-L. Li, R. M., Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:2075.
38. Chaudhary, P. M., M. Eby, A. Jasmin, A. Bookwalter, J. Murray, and L. Hood. 1997. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7:821.
39. Hubank, M., and D. G. Schatz. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22:5640.
40. Frazer, K. J., V. Pascual, and J. D. Capra, 1997. RDA of lymphocyte subsets. J. Immunol. Methods 207:1.
41. Liu, Y.-J., O. de Bouteiller, C. Arpin, I. Durand, and J. Banchereau. 1994. Five human mature β cell subsets. Adv. Exp. Med. Biol. 355:289.
42. Tsuda, E., M. Goto, S.-I. Mochizuki, K. Yano, F. Kobayashi, T. Morinaga, and K. Higashio. 1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234: 137.
43. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinoma. EMBO J. 8:1403.
44. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y.-J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
45. Chinnaiyan, A. M., K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990.
46. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
47. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994. Role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1:317.
48. Aicher, A., J. Westermann, S. Cayeux, G. Willimsky, K. Daemen, T. Blankenstein, W. Uckert, B. Dorken, and A. Pezzutto. 1997. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25:39.
49. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.-I. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597.
50. Pan, G., J. Ni, Y.-F. Wei, G.-L. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonistic decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815.
51. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W.I. Wood, et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
52. Degli-Esposti, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, and R. G. Goodwin. 1997. The novel receptor TRAIL-R4 induces NF-kB and protects against TRAIL-mediated apoptosis yet retains an incomplete death domain. Immunity 7:813.
53. Cheng, J., T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M. C. Kiefer, P. J. Barr, and J. D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the fas molecule. Science 263:1759.
54. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
55. van Essen, D., H. Kikutai, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620.
56. Tanaka, Y., D. H. Adams, and S. Shaw. 1993. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today 14:111.
57. Cascino, I., G. Fiucci, G. Papoff, and G. Ruberti. 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:2706.
58. Foy, T. M., A. Aruffo, J., Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
59. Arpin, C., J. D'echanet, C. Van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y.-J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720.
60. Emery, J. G., P. McDonnell, M. B. Burke, K. C. Deen, S. Lyn, C. Silverman, E. Dul, E. R. Appelbaum, C. Eichman, R. DiPrinzio, et al. 1998. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273:5117.